首页|静息心率对超高危动脉粥样硬化性心血管疾病患者全因死亡风险的影响

静息心率对超高危动脉粥样硬化性心血管疾病患者全因死亡风险的影响

扫码查看
目的:探讨静息心率对超高危动脉粥样硬化性心血管疾病(ASCVD)患者全因死亡风险的影响.方法:从2006~2020年开滦研究队列中纳入3 645例超高危ASCVD[采用《中国血脂管理指南(2023年)》中的定义]患者,排除 602 例静息心率数据缺失者后,最终分析纳入 3 043 例患者,根据确诊ASCVD后首次健康体检时的静息心率四分位水平,将其分为<68 次/min组(n=744)、68~74 次/min组(n=786)、75~80 次/min组(n=760)、≥81 次/min组(n=753).采用Cox比例风险回归模型比较不同静息心率水平及静息心率每升高10次/min对全因死亡风险的影响.采用限制性立方样条回归模型探讨静息心率与全因死亡风险之间的剂量-反应关系.采用寿命表法计算四组患者中的累积全因死亡率,并通过log-rank检验进行比较.结果:中位随访 5.81(3.46,9.64)年期间,772 例(25.37%)患者死亡.控制主要混杂因素后,分析结果显示:与静息心率<68 次/min组患者相比,75~80 次/min组、≥81 次/min组患者的全因死亡风险分别增加 24%(HR=1.24,95%CI:1.01~1.52,P=0.047)和 47%(HR=1.47,95%CI:1.20~1.81,P<0.001),而 68~74 次/min组患者的全因死亡风险差异无统计学意义(HR=1.06,95%CI:0.86~1.31,P=0.625).此外,静息心率每升高 10 次/min,全因死亡风险增加 13%(HR=1.13,95%CI:1.07~1.19,P<0.001).分层分析显示,静息心率每升高 10 次/min时,女性患者的全因死亡风险高于男性患者,<65 岁患者的全因死亡风险高于≥65 岁患者.限制性立方样条分析也显示,静息心率与全因死亡风险呈线性关联(Poverall<0.001,Pnon-linear=0.933),且静息心率>70 次/min时全因死亡风险显著增加.结论:静息心率升高与超高危ASCVD患者全因死亡风险增加相关,且二者呈线性关联.超高危ASCVD患者静息心率的合适干预切点可能为>75 次/min.
Impact of Resting Heart Rate on All-cause Mortality in Ultra-high Risk Atherosclerotic Cardiovascular Disease Patients
Objectives:To investigate the impact of resting heart rate on the risk of all-cause mortality in ultra-high risk atherosclerotic cardiovascular disease(ASCVD)patients.Methods:A total of 3 645 patients with ultra-high risk ASCVD(as defined in the 2023 Chinese Lipid Management Guidelines)were screened from the 2006 to 2020 Kailuan Study cohort,and after excluding 602 patients with missing resting heart rate,3 043 patients were included in the final analysis.Patients were divided into<68 beats/min group(n=744),68-74 beats/min group(n=786),75-80 beats/min group(n=760),and≥81 beats/min group(n=753)according to the resting heart rate.Cox proportional regression model was used to estimate the hazard ratios(HRs)and 95%CI for all-cause mortality associated with the different resting heart rate groups and every 10 beats/min increase of resting heart rate.The dose-effect relationship of resting heart rate level and all-cause mortality was assessed by a restricted cubic spline regression model.The Kaplan-Meier method was applied to calculate the cumulative all-cause mortality in different groups,and the differences were compared using log-rank test.Results:The median follow-up time was 5.81(3.46,9.64)years,there were 772(25.37%)all-cause deaths during follow up.After adjusting major confounding factors,the results showed that compared with<68 beats/min group,the risk of all-cause mortality in 75-80 beats/min group and≥81 beats/min group increased by 24%(HR=1.24,95%CI:1.01-1.52,P=0.047)and 47%(HR=1.47,95%CI:1.20-1.81,P<0.001),respectively;the risk of all-cause mortality in 68-74 beats/min group was similar(HR=1.06,95%CI:0.86-1.31,P=0.625).In addition,an increase of 10 beats/min in resting heart rate was associated with a 13%increase in the risk of all-cause mortality(HR=1.13,95%CI:1.07-1.19,P<0.001).In stratified analyses,it was found that for every 10 beats/min increase in resting heart rate,women faced a higher risk of all-cause mortality than men,and patients<65 years old faced a higher risk of all-cause mortality than patients≥65 years old.The restricted cubic spline analysis also showed that resting heart rate was linearly associated with the risk of all-cause mortality(Poverall<0.001,Pnon-linear=0.933),and the risk increased significantly with resting heart rate>70 beats/min.Conclusions:Increased resting heart rate is linearly associated with increased risk of all-cause mortality in patients with ultra-high risk ASCVD.The appropriate intervention cut-off point of resting heart rate for ultra-high risk ASCVD patients may be>75 beats/min.

ultra-high riskatherosclerotic cardiovascular diseaseresting heart rateall-cause mortalitycohort study

刘士贺、韩旭、刘倩、刘红敏、赵海燕、陈朔华、吴寿岭、吴云涛

展开 >

华北理工大学 临床医学院,唐山 063000

开滦总医院 心内科,唐山 063000

天津医科大学 临床医学院,天津 300070

兰州大学 临床医学院,兰州 730000

展开 >

超高危 动脉粥样硬化性心血管疾病 静息心率 全因死亡 队列研究

2024

中国循环杂志
中国医学科学院

中国循环杂志

CSTPCD北大核心
影响因子:2.803
ISSN:1000-3614
年,卷(期):2024.39(2)
  • 30